Home

DOUGLAS W LOSORDO

CIK 1583810 · Chief Medical Officer · last filed 2024-01-19

DOUGLAS W LOSORDO is a Chief Medical Officer who has filed 31 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for CVKD, was dated Jan 19, 2024. Current disclosed insider exposure totals $366 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$366

Companies

4

Total Filings

31

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
13 FOX MEADOW RD
SCARSDALE, NY 10583
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CVKD Chief Medical Officer — $1.09 — $0 1 2024-01-19
LGVN Director 50 $7.33 $366 $0 3 2023-12-26
LISATA THERAPEUTICS, INC. (CLBS) Delisted See Remarks 8,840 $6.40 $56.5K $0 21 2020-01-15
LISATA THERAPEUTICS, INC. (NBS) Delisted Chief Medical Officer 43,043 — — $0 6 2015-06-04

Recent Filings

31 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-01-19 CVKD Grant (A) — $0 EDGAR
2023-12-26 LGVN Grant (A) — $0 EDGAR
2022-12-22 LGVN Grant (A) — $0 EDGAR
2021-02-17 LGVN Grant (A) +5,000 $0 EDGAR
2020-01-15 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +14,209 -$15.9K EDGAR
2020-01-09 LISATA THERAPEUTICS, INC. (CLBS) Delisted Tax (F) −1,821 -$5.2K EDGAR
2019-01-16 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +13,841 $0 EDGAR
2019-01-10 LISATA THERAPEUTICS, INC. (CLBS) Delisted Tax (F) −1,795 -$8.3K EDGAR
2018-06-21 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +6,893 $59.6K EDGAR
2018-04-10 LISATA THERAPEUTICS, INC. (CLBS) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 31
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.